vs
4D Molecular Therapeutics, Inc.（FDMT）与MERCANTILE BANK CORP（MBWM）财务数据对比。点击上方公司名可切换其他公司
4D Molecular Therapeutics, Inc.的季度营收约是MERCANTILE BANK CORP的1.3倍（$85.1M vs $67.6M），MERCANTILE BANK CORP净利率更高（33.6% vs 22.8%，领先10.8%），过去两年4D Molecular Therapeutics, Inc.的营收复合增速更高（5412.6% vs 9.1%）
4D Molecular Therapeutics是一家临床阶段生物技术企业，专注于研发靶向腺相关病毒（AAV）基因疗法，核心在研产品覆盖眼科、心脏病学、肺部疾病领域，为全球存在未满足医疗需求的罕见病和常见病患者提供新型治疗方案。
泰米尔纳德商业银行（TMB）是一家印度银行，总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年，最初名为纳达尔银行，1962年11月更名为泰米尔纳德商业银行，以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
FDMT vs MBWM — 直观对比
营收规模更大
FDMT
是对方的1.3倍
$67.6M
净利率更高
MBWM
高出10.8%
22.8%
两年增速更快
FDMT
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $85.1M | $67.6M |
| 净利润 | $19.4M | $22.7M |
| 毛利率 | — | — |
| 营业利润率 | 17.3% | — |
| 净利率 | 22.8% | 33.6% |
| 营收同比 | 8508900.0% | — |
| 净利润同比 | 139.1% | 16.1% |
| 每股收益（稀释后） | $0.43 | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FDMTMBWM
| Q1 26 | — | $67.6M | ||
| Q4 25 | $85.1M | $62.1M | ||
| Q3 25 | $90.0K | $62.4M | ||
| Q2 25 | $15.0K | $60.9M | ||
| Q1 25 | $14.0K | $57.3M | ||
| Q4 24 | $1.0K | $58.5M | ||
| Q3 24 | $3.0K | $58.0M | ||
| Q2 24 | $5.0K | $56.8M |
净利润FDMTMBWM
| Q1 26 | — | $22.7M | ||
| Q4 25 | $19.4M | $22.8M | ||
| Q3 25 | $-56.9M | $23.8M | ||
| Q2 25 | $-54.7M | $22.6M | ||
| Q1 25 | $-48.0M | $19.5M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | $-43.8M | $19.6M | ||
| Q2 24 | $-35.0M | $18.8M |
营业利润率FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | 17.3% | 42.0% | ||
| Q3 25 | -67983.3% | 44.0% | ||
| Q2 25 | -396373.3% | 42.6% | ||
| Q1 25 | -383007.1% | 42.0% | ||
| Q4 24 | — | 39.7% | ||
| Q3 24 | -1704400.0% | 42.4% | ||
| Q2 24 | -849120.0% | 41.4% |
净利率FDMTMBWM
| Q1 26 | — | 33.6% | ||
| Q4 25 | 22.8% | 36.8% | ||
| Q3 25 | -63195.6% | 38.1% | ||
| Q2 25 | -364386.7% | 37.1% | ||
| Q1 25 | -342657.1% | 34.1% | ||
| Q4 24 | — | 33.5% | ||
| Q3 24 | -1461433.3% | 33.8% | ||
| Q2 24 | -699060.0% | 33.1% |
每股收益（稀释后）FDMTMBWM
| Q1 26 | — | $1.32 | ||
| Q4 25 | $0.43 | $1.41 | ||
| Q3 25 | $-1.01 | $1.46 | ||
| Q2 25 | $-0.98 | $1.39 | ||
| Q1 25 | $-0.86 | $1.21 | ||
| Q4 24 | — | $1.20 | ||
| Q3 24 | $-0.79 | $1.22 | ||
| Q2 24 | $-0.63 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $402.7M | — |
| 总债务越低越好 | — | $1.5M |
| 股东权益账面价值 | $505.7M | $736.9M |
| 总资产 | $566.7M | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | $402.7M | — | ||
| Q3 25 | $305.1M | — | ||
| Q2 25 | $293.2M | — | ||
| Q1 25 | $321.4M | — | ||
| Q4 24 | $424.9M | — | ||
| Q3 24 | $501.9M | — | ||
| Q2 24 | $541.9M | — |
总债务FDMTMBWM
| Q1 26 | — | $1.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FDMTMBWM
| Q1 26 | — | $736.9M | ||
| Q4 25 | $505.7M | $724.9M | ||
| Q3 25 | $369.0M | $657.6M | ||
| Q2 25 | $420.9M | $631.5M | ||
| Q1 25 | $469.7M | $608.3M | ||
| Q4 24 | $510.6M | $584.5M | ||
| Q3 24 | $552.9M | $583.3M | ||
| Q2 24 | $588.3M | $551.2M |
总资产FDMTMBWM
| Q1 26 | — | $6.9B | ||
| Q4 25 | $566.7M | $6.8B | ||
| Q3 25 | $424.0M | $6.3B | ||
| Q2 25 | $473.6M | $6.2B | ||
| Q1 25 | $515.7M | $6.1B | ||
| Q4 24 | $560.4M | $6.1B | ||
| Q3 24 | $604.0M | $5.9B | ||
| Q2 24 | $620.1M | $5.6B |
负债/权益比FDMTMBWM
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.6M | — |
| 自由现金流经营现金流 - 资本支出 | $28.5M | — |
| 自由现金流率自由现金流/营收 | 33.5% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.47× | — |
| 过去12个月自由现金流最近4个季度 | $-109.9M | — |
8季度趋势，按日历期对齐
经营现金流FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $18.0M | ||
| Q3 25 | $-46.5M | $23.1M | ||
| Q2 25 | $-43.4M | $-7.8M | ||
| Q1 25 | $-47.8M | $-3.0M | ||
| Q4 24 | $-134.6M | $101.1M | ||
| Q3 24 | $-29.4M | $-8.1M | ||
| Q2 24 | $-30.2M | $9.1M |
自由现金流FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | $28.5M | — | ||
| Q3 25 | $-46.6M | — | ||
| Q2 25 | $-43.4M | — | ||
| Q1 25 | $-48.4M | — | ||
| Q4 24 | $-138.4M | — | ||
| Q3 24 | $-31.2M | — | ||
| Q2 24 | $-30.6M | — |
自由现金流率FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | 33.5% | — | ||
| Q3 25 | -51765.6% | — | ||
| Q2 25 | -289620.0% | — | ||
| Q1 25 | -345635.7% | — | ||
| Q4 24 | -13837100.0% | — | ||
| Q3 24 | -1038966.7% | — | ||
| Q2 24 | -611840.0% | — |
资本支出强度FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 101.1% | — | ||
| Q2 25 | 440.0% | — | ||
| Q1 25 | 4507.1% | — | ||
| Q4 24 | 378600.0% | — | ||
| Q3 24 | 59266.7% | — | ||
| Q2 24 | 6980.0% | — |
现金转化率FDMTMBWM
| Q1 26 | — | — | ||
| Q4 25 | 1.47× | 0.79× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | -0.35× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | — | 5.15× | ||
| Q3 24 | — | -0.41× | ||
| Q2 24 | — | 0.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FDMT
暂无分部数据
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
